• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Hygienic Packaging Technology

    Trends in Solid Oral Dosage Delivery

    5 Reasons Paper Has No Place in Contract Manufacturing

    Injectable Drug Delivery Trends

    Pharmaceutical Manufacturing Equipment Trends
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    AGC Biologics Expands Cell and Gene Facility in Italy

    Celonic to Boost Cell & Gene Therapy Production

    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

    Aptamer Extends Collaboration with AstraZeneca

    Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    AGC Biologics Expands Cell and Gene Facility in Italy

    Celonic to Boost Cell & Gene Therapy Production

    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

    Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark

    Reed-Lane Facility Virtual Tour
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Reed-Lane Facility Virtual Tour

    Hygienic Packaging Technology

    Reshaping the Pharmaceutical Supply Chain

    Serialization: Level 5 Solution

    Covectra Introduces Next-Gen Serialization Solution
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Data Management Trends

    AGC Biologics Expands Cell and Gene Facility in Italy

    Celonic to Boost Cell & Gene Therapy Production

    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

    Aptamer Extends Collaboration with AstraZeneca
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Guide to Maintaining Validation of Older Facilities: Why, When and How

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Cytovance Biologics

    Syngene

    Adare Pharma Solutions

    Reed-Lane

    Almac Group
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Baxter BioPharma Solutions

    Reed-Lane

    Almac Group

    Alcami

    Emergent BioSolutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Market on the Rise: Parenterals

    A look at trends and challenges in today’s parenteral manufacturing and development market.

    Market on the Rise: Parenterals
    Related CONTENT
    • Stevanato Group
    • Mogene
    • AAPS Exhibitor List
    • Vetio Animal Health
    • Contracting And Outsourcing Exhibitor List
    Emilie Branch, Strategic Content Manager, Nice Insight11.13.18
    As the chosen dosage form for next-generation therapies, parenteral manufacturing has advanced substantially over the last decade. As the Food and Drug Administration (FDA) calls for the serialization of all drug products, ensuring quality in parenterals has become especially important for contract development and manufacturing organizations, with many adding quality-by-design (QbD) into operations. Among other trends in this rising market is the call for sustainability in production and even “green packaging” delivery methods, as well as movement toward flexibility in operations.

    Market growth
    The rise of drugs that require more complex formulations, such as biologics, has affected the pharmaceutical supply chain in numerous ways. Biologic drugs are overwhelmingly delivered intravenously; this has notably shaped the parenteral market. Parenteral administration is a key area of opportunity, especially as biologics have become mainstream—with no indication of a slowdown. Instead, the global parenteral packaging market is expected to experience significant growth. According to Zion Market Research, this market was valued at $8.69 billion in 2017. By the end of 2024, however, the parental packaging sector is expected to command $18.2 billion with a compound annual growth rate (CAGR) of 11.14%.1

    Meeting the demands of a global population
    The drivers for this increase include a spike in the total global geriatric population and an overall rise in the rates of diseases and chronic conditions within the population. This is observed internationally. As developing nations now have increased access to pharmaceuticals and biotechnology, parental treatments will continue to be distributed and administered worldwide.

    North America makes up the largest segment of the parenteral market, with Asia expected to grow significantly. According to Zion Market Research, some of the most formidable players in the flexible parenteral product market include RPC Group, Unilife Corporation, Gerresheimer AG, Stevanato Group, Berry Plastics Corporation, Nipro Corporation, MeadWestvaco Corporation, Schott AG, Dickinson and Company, Inc., and West Pharmaceutical Services.1

    Call for sustainability
    A noticeable trend in the packaging of parenterals is the use of biodegradable plastics, which is predicted to drive market growth and innovation, as well as expansion. There is a global demand for the use of “green” or sustainable packaging in the pharmaceutical industry, which is indicative of a greater shift.1

    Stemming from this same change in demand, pharma companies are increasingly highlighting their corporate social responsibility (CSR) departments. For instance, Servier has committed to sustainability as part of their CSR positioning. According to Allain de Wilde, corporate social responsibility director, and Loïc Allanos, corporate social responsibility manager for Servier, sustainability does not need to undermine bottom lines. “A formal CSR strategy enables communication of company goals for creating positive social and environmental impacts in collaboration with all internal and external stakeholders—from employees to customers/partners. Our objective is to enable sustainable development,” they said. “To do so, we are taking steps that go beyond legal obligations; it is a business strategy of Servier to be socially responsible as a means for creating value for all stakeholders and growth opportunities for the company.”2

    Flexible packaging and development
    Parenteral packaging makes up a broad category of a segmented market, comprising an array of packaging options, such as plastic, glass, small and large volume bags, ampoules, vials, prefilled syringes, and cartridges, as well as ready-to-mix systems.1 As packaging has become more flexible, so has the machinery needed for its production. Flexible machine platforms give industry developers and manufacturers the ability to make more kinds of products. Christian Treitel, director of business development pharma, Bosch Packaging Technology, explained the difference flexibility has made in manufacturing. “A wider variety of packaging styles—ready-to-fill syringes and, recently, vials and cartridges—and flexible machine platforms offer pharmaceutical manufacturers the flexibility for different products and requirements,” he said.3

    Hope for an automation solution
    Although the FDA has recommended automation in pharmaceutical manufacturing, when it comes to biologics and more advanced products, the technology has yet to be developed. Continuous manufacturing is attractive because it offers both time and cost benefits. Automated production lines are able to run 24/7 while reducing the cost of labor. This would be a tremendous industry benefit and could mean more drug product at reduced costs. Though automation technology is easier to achieve in oral solid dose and small-molecule API production, the quest for continuous solutions in the manufacture of next-generation therapies will continue.

    However, challenges to continuous manufacturing persist. For instance, procuring the proper machine may be an unexpected hurdle in production, especially if a manufacturer has a relationship with a single equipment supplier. The materials of the machine must also be compatible with the chemical formulation; for instance, if a machine is stainless steel, it is crucial to avoid acidic compounds for risk of erosion.4

    Putting single-use tech to use
    A single-use strategy is typically employed in parenteral manufacturing and is used for antibodies, proteins, vaccines, cell therapy, and gene therapy. Although this is the current manufacturing solution, a single-use strategy also presents its own unique set of challenges.

    Concerns associated with single-use technologies include the compatibility of parts among different suppliers. “Implementing single-use brings with it new challenges that traditional facilities do not face, such as ensuring skids from different vendors have compatible connectors and common spare components such as clamps,” said Steve Miller, global head of next generation system development, life science, upstream and systems business, Field Millipore S.A.S. Process transfer is another challenge, as is scale-down or scale-up, depending on the size of a reactor. If a typical reactor is 50 L and commercial scale is 2000 L, scale-up or scale-down may not be feasible or come with too great a cost.5

    Implementing Quality-by-Design
    One of the most widespread trends in parenteral development has been the focus on quality in manufacturing. Companies are incorporating QbD into their processes in efforts to eliminate contaminants. Particulate contaminants in parenteral drug products have contributed to drug shortages, which is a worst-case outcome that no company wants to risk.

    Unfortunately, the intricacies of the development process have led to more opportunities for particulate matter to affect production. This is particularly true for parenteral packaging processes, such as with pre-filled syringes—it is not uncommon for proteins to interact with the components of the packaging systems under certain conditions. Manufacturers are looking to combat this issue by drawing awareness so that it can be prevented and by optimizing all internal quality management systems through audits, visual inspection, and the design of systems for product monitoring that will alert manufacturers to any potential risk of a hazard occurring.

    The goal of QbD is to manufacture correctly from the start. Time and cost are the main challenges to ensuring a facility’s QbD. A QbD approach to quality requires increased testing and labor in research and is often the outcome of a strategic partnership with suppliers—though finding the right one can be a hurdle. However, once implemented,  issues will be reduced and there will be a financial benefit over the long term and improved operations overall.

    Pushing parenterals globally
    As both the market and the demand for parenteral products continue to grow, so will this segment. The next breakthrough will likely be delivered parenterally. As patient populations become more comfortable with self-administration, parenterals will continue to grow internationally. 

    References
    1. https://globenewswire.com/news-release/2018/09/04/1564617/0/en/Global-Parenteral-Packaging-Market-Will-Reach-USD-18-20-Billion-By-2024-Zion-Market-Research.html
    2. https://www.pharmasalmanac.com/articles/corporate-social-responsibility-as-a-driver-for-improved-sustainability
    3. https://www.contractpharma.com/issues/2018-04-01/view_features/continuous-vs-batch-production/53332
    4. http://www.pharmtech.com/integrating-single-use-systems-pharma-manufacturing
    5. http://www.pharmtech.com/parenterals-particulates-and-quality-design
    Related Searches
    • contractpharma
    • facility
    • serialization
    • vaccines
    Suggested For You
    Stevanato Group Stevanato Group
    Mogene Mogene
    AAPS Exhibitor List AAPS Exhibitor List
    Vetio Animal Health Vetio Animal Health
    Contracting And Outsourcing Exhibitor List Contracting And Outsourcing Exhibitor List
    Bosch Introduces Sigpack HML Machine Bosch Introduces Sigpack HML Machine
    PMI BioPharma Solutions Names CEO PMI BioPharma Solutions Names CEO
    Financial Report: West Pharmaceutical Services Financial Report: West Pharmaceutical Services
    Your CMO for Sterile Injectables Your CMO for Sterile Injectables
    CPhI CPhI's 15th Annual Pharma Awards
    West Receives CPhI Award West Receives CPhI Award
    Pre-sterilized Packaging Pre-sterilized Packaging
    Semi-Solid Dosage Forms Semi-Solid Dosage Forms
    West Introduces Integrated Solutions Program West Introduces Integrated Solutions Program
    Grand River Aseptic Manufacturing CEO Details Services Grand River Aseptic Manufacturing CEO Details Services

    Related Features

    • Solid Dosage/Semi-solids
      Hygienic Packaging Technology

      Hygienic Packaging Technology

      Growing consumer demand for health products highlights hygienic packaging.
      John Brown, Vice President of Global Marketing, Selig 03.01.21

    • Drug Delivery | Solid Dosage/Creams/Ointments
      Trends in Solid Oral Dosage Delivery

      Trends in Solid Oral Dosage Delivery

      Capsule demand continues to rise due to this delivery system’s versatility.
      Anita Solanki, Milind Biyani and Jnanadeva Bhat, PhD , ACG Capsules 03.01.21

    • Information Technology
      5 Reasons Paper Has No Place in Contract Manufacturing

      5 Reasons Paper Has No Place in Contract Manufacturing

      Digital solutions create more efficient manufacturing processes and eliminate delays.
      Dave Edwards, Chief Revenue Officer, MasterControl 03.01.21


    • Drug Delivery | Parenterals
      Injectable Drug Delivery Trends

      Injectable Drug Delivery Trends

      How medication trends are driving the shift to patient-friendly drug delivery systems.
      Peter Soelkner, Managing Director, Vetter 03.01.21

    • Pharmaceutical Manufacturing  Equipment Trends

      Pharmaceutical Manufacturing Equipment Trends

      Demand for flexibility remains the driving force behind equipment systems.
      Kristin Brooks, Managing Editor, Contract Pharma 03.01.21

    • Drug Delivery | Solid Dosage/Creams/Ointments
      Oral Solids:   Market & Technology Trends

      Oral Solids: Market & Technology Trends

      Oral solids remain the preferred route of drug delivery due to their cost-effectiveness, ease of manufacturing, and patient-friendly dose form options.
      Tim Wright, Editor, Contract Pharma 03.01.21


    • Nutraceutical Manufacturing:  Meeting the Challenges of Today, Planning for  Tomorrow

      Nutraceutical Manufacturing: Meeting the Challenges of Today, Planning for Tomorrow

      Companies continue balancing high demand, supply disruption, and worker safety during the pandemic.
      Sean Moloughney, Editor, Nutraceuticals World 03.01.21

    • 2021 Contract  Manufacturing Survey

      2021 Contract Manufacturing Survey

      Our fourth annual audience poll indicates continued reliance on manufacturing partners, particularly for small businesses.
      Sean Moloughney, Editor, Nutraceuticals World 03.01.21

    • APIs
      Small Molecule Development Trends

      Small Molecule Development Trends

      A Q&A with Cambrex Edinburgh’s site director, Mark Benger.
      Tim Wright, Editor, Contract Pharma 03.01.21


    • APIs | Cytotoxics and High Potency Manufacturing
      Challenges & Opportunities Facing Small & Emerging Biopharma Companies

      Challenges & Opportunities Facing Small & Emerging Biopharma Companies

      A Q&A with Christian Dowdeswell, vice president and head of commercial development for small molecules at Lonza.
      Tim Wright, Editor, Contract Pharma 03.01.21

    • Drug Delivery | Solid Dosage/Creams/Ointments
      Medicated Chewing Gum: A Modern Oral Drug Delivery System

      Medicated Chewing Gum: A Modern Oral Drug Delivery System

      Development and manufacture of medicated chewing gum continues to gain momentum.
      Rukayat Adedeji, Contributing Writer 03.01.21

    • APIs
      Small Molecule API CDMO: A Capital Intensive Business?

      Small Molecule API CDMO: A Capital Intensive Business?

      Exploring small molecule API market trends.
      Dr. Michele Jermini and Dr. Enrico Polastro, Contributing Writers 03.01.21


    • Serialization
      Serialization: Level 5 Solution

      Serialization: Level 5 Solution

      Why a Level 5 solution is required for small pharma companies to fully harness serialization investment.
      Steve Wood, President & CEO, Covectra 03.01.21

    • Solid Dosage/Creams/Ointments
      High Drug Loading Amorphous Solid Dispersions

      High Drug Loading Amorphous Solid Dispersions

      A Novel Tablet Architecture for Amorphous Solid Dispersions to Achieve High Drug Loadings
      Deanna Mudie and Aaron Stewart, Lonza 01.27.21

    • Parenterals
      Parenteral Drug Delivery Trends

      Parenteral Drug Delivery Trends

      A Q&A with Lubrizol Life Science Health’s CDMO Division President, Rob Lee.
      Kristin Brooks, Managing Editor, Contract Pharma 01.27.21

    Trending
    • Four Female Leaders Appointed To Cell & Gene CDMO
    • BMS Expands Cell Therapy Manufacturing Capabilities
    • Reed-Lane Facility Virtual Tour
    Breaking News
    • AGC Biologics Expands Cell and Gene Facility in Italy
    • Celonic to Boost Cell & Gene Therapy Production
    • Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie
    • Aptamer Extends Collaboration with AstraZeneca
    • Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark
    View Breaking News >
    CURRENT ISSUE

    March 2021

    • Hygienic Packaging Technology
    • Trends in Solid Oral Dosage Delivery
    • 5 Reasons Paper Has No Place in Contract Manufacturing
    • Injectable Drug Delivery Trends
    • Pharmaceutical Manufacturing Equipment Trends
    • Oral Solids: Market & Technology Trends
    • Nutraceutical Manufacturing: Meeting the Challenges of Today, Planning for Tomorrow
    • 2021 Contract Manufacturing Survey
    • Small Molecule Development Trends
    • Challenges & Opportunities Facing Small & Emerging Biopharma Companies
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Thymoquinone Inhibits Viral Infection in In Vitro Settings, New Study Finds
    IFT Transitions 2021 Annual Event to Digital Experience
    NY Federal Judge Enters Permanent Injunction Against Dietary Supplement Manufacturer
    Coatings World

    Latest Breaking News From Coatings World

    Sherwin-Williams Announces Resignation of President, COO
    Ashland Completes Expansion, Relocation of Viatel Bioresorbable Polymers Manufacturing Facility
    Evonik Receives Sustainability Award from EcoVadis
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Cretex CFO Announces Retirement
    New AI-Based Tool Developed for Coronary Artery Analysis, Intervention Planning
    First Reported Use of Pulse Biosciences' CellFX System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    AGC Biologics Expands Cell and Gene Facility in Italy
    Celonic to Boost Cell & Gene Therapy Production
    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Ulta Beauty Opens in Herald Square
    Elizabeth Arden Taps Sui He as Global Brand Ambassador
    Natura &Co Outperforms the Global Market in Q4 2020
    Happi

    Latest Breaking News From Happi

    What You're Reading on Happi.com
    Indie Beauty Innovators Wanted
    Cosmetic Chemists Seek Mentors
    Ink World

    Latest Breaking News From Ink World

    Massilly North America Adds Koenig & Bauer MetalStar 3 Metal Decorating Press
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Arjobex America welcomes Maggie Naberezny to sales team
    Henkel publishes 30th Sustainability Report
    Avery Dennison Smartrac launches new Circus Pro inlays
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    FPInnovations Develops Biodegradable Mask
    Sani Professional Sanitizing and Disinfecting Products Approved by EPA
    Autefa Solutions Offers Fully Automated Line for Protective Mask Production
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Colfax Decides to Divide Its Businesses
    Stryker Corp.'s 2020 Sales Slip 3.6 Percent
    Bioventus Appoints Managing Director, China and Asia Pacific
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login